<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Li Y</submitter><funding>Beijing Hospital Management Center-Climb Plan</funding><funding>National Science Foundation of China</funding><funding>Youth Project of Beijing Natural Science Foundation</funding><funding>Capital Medical Science Innovation Center Scientific Research Pioneering Project</funding><funding>Young Scientists Program of Beijing Tiantan Hospital, Capital Medical University</funding><funding>National Natural Science Foundation of China</funding><funding>Ministry of Science and Technology of China-National Key Research Project</funding><funding>Capital Medical University Young Scholars</funding><pagination>1901-1909</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11630882</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>45(12)</volume><pubmed_abstract>&lt;h4>Background and purpose&lt;/h4>The underlying transcriptomic signatures driving brain functional alterations in MS and neuromyelitis optica spectrum disorder (NMOSD) are still unclear.&lt;h4>Materials and methods&lt;/h4>Regional fractional amplitude of low-frequency fluctuation (fALFF) values were obtained and compared among 209 patients with MS, 90 patients with antiaquaporin-4 antibody (AQP4)+ NMOSD, 49 with AQP4- NMOSD, and 228 healthy controls from a discovery cohort. We used partial least squares (PLS) regression to identify the gene transcriptomic signatures associated with disease-related fALFF alterations. The biologic process and cell type-specific signature of the identified PLS genes were explored by enrichment analysis. The correlation between PLS genes and clinical variables was exp</pubmed_abstract><journal>AJNR. American journal of neuroradiology</journal><pubmed_title>Imaging Transcriptomics of Brain Functional Alterations in MS and Neuromyelitis Optica Spectrum Disorder.</pubmed_title><pmcid>PMC11630882</pmcid><funding_grant_id>2022YFC2009904</funding_grant_id><funding_grant_id>NO.7244328</funding_grant_id><funding_grant_id>822020840</funding_grant_id><funding_grant_id>DFL20220503</funding_grant_id><funding_grant_id>82330057</funding_grant_id><funding_grant_id>CX23YQ06</funding_grant_id><funding_grant_id>None</funding_grant_id><funding_grant_id>NO.YSP202205</funding_grant_id><pubmed_authors>Li H</pubmed_authors><pubmed_authors>Zhuo Z</pubmed_authors><pubmed_authors>Zhang N</pubmed_authors><pubmed_authors>Han X</pubmed_authors><pubmed_authors>Tian D</pubmed_authors><pubmed_authors>Li K</pubmed_authors><pubmed_authors>Guo M</pubmed_authors><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Zhang X</pubmed_authors><pubmed_authors>Shi F</pubmed_authors><pubmed_authors>Zhou F</pubmed_authors><pubmed_authors>Xu X</pubmed_authors><pubmed_authors>Sun J</pubmed_authors><pubmed_authors>Duan Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Imaging Transcriptomics of Brain Functional Alterations in MS and Neuromyelitis Optica Spectrum Disorder.</name><description>&lt;h4>Background and purpose&lt;/h4>The underlying transcriptomic signatures driving brain functional alterations in MS and neuromyelitis optica spectrum disorder (NMOSD) are still unclear.&lt;h4>Materials and methods&lt;/h4>Regional fractional amplitude of low-frequency fluctuation (fALFF) values were obtained and compared among 209 patients with MS, 90 patients with antiaquaporin-4 antibody (AQP4)+ NMOSD, 49 with AQP4- NMOSD, and 228 healthy controls from a discovery cohort. We used partial least squares (PLS) regression to identify the gene transcriptomic signatures associated with disease-related fALFF alterations. The biologic process and cell type-specific signature of the identified PLS genes were explored by enrichment analysis. The correlation between PLS genes and clinical variables was exp</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Dec</publication><modification>2026-06-05T20:57:29.598Z</modification><creation>2026-05-21T03:13:09.995Z</creation></dates><accession>S-EPMC11630882</accession><cross_references><pubmed>39510804</pubmed><doi>10.3174/ajnr.A8480</doi><doi>10.3174/ajnr.a8480</doi></cross_references></HashMap>